#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Primitive neuroectodermal tumour Dupuytren's contracture Progressive multifocal leukoencephalopathy Astrocytoma malignant Gastrointestinal neuroendocrine tumour Selective polysaccharide antibody deficiency Measles Meningococcal immunisation Deafness Granulomatosis with polyangiitis Congenital ectodermal dysplasia Burkitt's lymphoma Interstitial lung disease Essential thrombocythaemia Hereditary angioedema More trials…

    Learn about Rare Diseases

    Extranodal marginal zone B-cell lymphoma (MALT type) – Basic Information Mantle cell lymphoma refractory – Trials in Disease Glomerulonephritis rapidly progressive Advanced systemic mastocytosis – Basic Information Haemophilia B without inhibitors – Life with Disease Loeys-Dietz syndrome – Treatment Chordoma – Basic Information Vascular malformation – Diagnostics Toxic epidermal necrolysis – Diagnostics Skin angiosarcoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Insulin Glargine Ponsegromab Odm-212 Topotecan Anastrozole Dexamethasone Phosphate Rifamycin Sodium Metamizole Sodium Monohydrate Glenzocimab Mps-103 Carbamazepine (Ph. Eur.) Caspofungin SEVABERTINIB Methadone Hydrochloride Magnesium Sulfate Gliclazide Soya-Bean Oil Refined Mps-213 Budesonide Ds-3939A More therapies…

    Learn about Your Condition

    Affective disorder Psoriatic arthropathy Breast cancer stage II Thyroid disorder Haemodialysis Periodontitis Sciatica Arthralgia Epicondylitis Laryngeal cancer stage II Skin papilloma Raynaud's phenomenon Anaemia of pregnancy Renal impairment MELAS syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on Water Absorption in the Brain for Adults with Hydrocephalus Using O15-Water

    Recruiting

    3 1 1
    Investigated Diseases:
    • Hydrocephalus
    Investigated Drugs:
    • O15-Water
    Norway

  • Study on the Effectiveness of Optune with Temozolomide and Pembrolizumab in Patients with Newly Diagnosed Glioblastoma

    Recruiting

    3 1 1
    Investigated Drugs:
    • Pembrolizumab
    • Temozolomide
    Czechia France Germany Italy Poland Spain

  • Study Comparing Treosulfan and Melphalan with Fludarabine for Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS) Undergoing Transplantation

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Myelodysplastic syndrome
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Melphalan
    • Treosulfan
    • Fludarabine
    Germany

  • Study on Dinutuximab Beta and Drug Combination for Children, Teens, and Adults with GD2-Positive Ewing Sarcoma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Ewing’s sarcoma
    Investigated Drugs:
    • Dinutuximab Beta
    • Mesna
    • Filgrastim
    Austria Czechia Germany Sweden

  • Study on the Safety and Effects of YTB323, Tocilizumab, and Cyclophosphamide in Patients with Relapsing Multiple Sclerosis Who Have Active Disease Despite Treatment

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Cyclophosphamide
    • Fludarabine Phosphate
    • Rapcabtagene Autoleucel
    France Germany Italy Spain

  • Study on Preventing Heart Transplant Rejection in Children Using Autologous Treg Cells (thyTreg)

    Recruiting

    1 1 1
    Investigated Diseases:
    • Heart transplant
    Spain
Previous Page
1 … 241 242 243 244 245 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!